MedPath

aboratory monitoring and the anti-coagulant effect of Edoxaban after total knee arthroplasty

Not Applicable
Conditions
The patients who will be performed TKA/THA
Registration Number
JPRN-UMIN000017220
Lead Sponsor
Hokkaido University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

bleeding risks bleeding tendency bleeding history uncontrollable hypertension Operation history within 30 days uncontrollable DM low body weight less than 50 kg Renal failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of DVT
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath